Surgical Procedure, Unspecified
Conditions
Brief summary
This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia.
Detailed description
A solid body of published and preliminary evidence leveraging systematic phenotypic and whole cell genome analysis and innovative surveillance technology has provided great insight into the epidemiology of perioperative bacterial transmission and healthcare-associated infection (HAI) development. This work has led us to three primary assertions that serve as the foundation of our scientific premise: 1) Further progress towards HAI prevention is needed, 2) Prevention of perioperative ESKAPE transmission is an important improvement target, and 3) An evidence-based, multi-faceted program can reduce perioperative ESKAPE transmission. Further work to generate intraoperative hand hygiene improvement is indicated. We hypothesize that the proposed program will generate sustained reductions in OR ESKAPE exposure and S. aureus transmission that will lead to sustained reductions in perioperative HAIs.
Interventions
DEVICEPersonalized Body-Worn Alcohol Dispenser
This is an alcohol dispenser that will be worn on the Anesthesia Providers scrub pants, near the hip. It will be worn by both the attending physician and the resident physician/CRNA/SRNA. The device is produced by Georgia-Pacific.
Sponsors
RDB Bioinformatics
Georgia-Pacific
University of Iowa
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Adult patients undergoing surgery requiring general anesthesia and peripheral IV and/or central line placement.
Exclusion criteria
Pediatric patient, not requiring general anesthesia and/or IV/central line placement.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ESKAPE transmission events with and without the body worn device | Up to 96 hours from the surgial procedure | Reduce the number of Enterococcus, Staphylococcus aureus, Pseudomonas, and other gram-negative (i.e., Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) transmission events |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The epidemiology of ESKAPE transmission events | Up to 90 days from surgery | To characterize the epidemiology of ESKAPE transmission with and without the device according to incidence. |
| 90-Day Healthcare-Associated Infections | 90 days following surgery | Number of infections occurring within 90 days of surgery |
Countries
United States
Outcome results
None listed